FDA-Drug2021-09-22Class III
Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21
Meitheal Pharmaceuticals Inc
Hazard
Failed Impurities/Degradation Specifications
Sold states
Nationwide within the USA and India
Affected count
1,160 ten-pack cartons
Manufactured in
8700 W Bryn Mawr Ave Ste 600, N/A, Chicago, IL, United States
Products
Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0801-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief